ARTICLE | Clinical News
Tysabri natalizumab regulatory update
September 1, 2008 7:00 AM UTC
FDA informed healthcare professionals of 2 previously reported cases of progressive multifocal leukoencephalopathy (PML) in patients with multiple sclerosis (MS) receiving Tysabri natalizumab monother...